Early Digi-physical Support During Breastfeeding Initiation - a Single-blind Randomized Controlled Trial

Sponsor
Region Stockholm (Other)
Overall Status
Recruiting
CT.gov ID
NCT06044636
Collaborator
(none)
400
1
2
22.4
17.8

Study Details

Study Description

Brief Summary

The purpose of this Randomized Controlled Trial is to develop and evaluate a digi-physical intervention within primary health care lactation counselling and breastfeeding support to promote exclusive breastfeeding rates during the first 6 months after birth and to prevent depressive symptoms.

The project addresses parents during pregnancy week 20 and 32 and will continue during the infant's first year of life. All participants will get access to an evidence-based information package (theory and practical advises) during pregnancy.

Study aim is to develop and evaluate digital evidence-based information materials and continuous support for both parents in order to increase prevalence of exclusive breastfeeding and duration as well as decreasing the risks of symptoms of post-partum depression.

Condition or Disease Intervention/Treatment Phase
  • Other: Digi-physical breastfeeding support
N/A

Detailed Description

The project design is a single-blind randomized controlled trial.

The intervention group will receive:
  • Digital support by chat with a lactation consultant for immediate breastfeeding support two-three weeks after delivery

  • Extended home visits by pediatric nurses providing extra knowledge and support about lactation

  • Extra support by health care providers educated in lactation counseling when needed.

More specific purposes are:
  • Compare the prevalence of exclusive breastfeeding until 6 months and duration of breastfeeding up to one year between the intervention and the control group. (Primary outcome)

  • Compare prevalence of depression symptoms between the intervention and control group. (Secondary outcome)

  • Strengthening parents' self-efficacy in breastfeeding their child.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Early Digi-physical Support During Breastfeeding Initiation Linked to Continued Support at Breastfeeding Clinic - a Single-blind Randomized Controlled Trial
Actual Study Start Date :
Jan 18, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention Group

Interventions: At discharge from the maternity ward: contact with lactation consultant (breastfeeding support and care) via the support hotline with chat as soon as questions or problems arise. The hotline will be available during the whole project period. After discharge from the maternity ward: paediatric nurse from Child Health Care Unit (CHC) will contact families and make a home visit (physical or digital), giving extended lactation advice and support. Additional home visits if needed. After discharge until one year after childbirth: possibility to get contact with specialized lactation consultant/nurse at lactation counseling units if needed. The intervention group will follow current healthcare routines in the Region Stockholm and will get access to an evidence-based information package about breastfeeding from pregnancy week 20.

Other: Digi-physical breastfeeding support
Breastfeeding support after birth is provided via chat Extended home visits by a pediatric nurse after discharge from the maternity ward Extra support from a lactation counselor when needed after discharge until one year after childbirth
Other Names:
  • breastfeeding councelling
  • No Intervention: Control Group

    The control group will follow current healthcare routines in the Region Stockholm and will get access to an evidence-based information package about breastfeeding from pregnancy week 20.

    Outcome Measures

    Primary Outcome Measures

    1. Exclusive breastfeeding at 6 months and duration of breastfeeding [From birth until child is one year old]

      Compare the prevalence of exclusive breastfeeding until 6 months and duration of breastfeeding up to one year between the intervention and the control group

    Secondary Outcome Measures

    1. Prevalence of depression symptoms [From birth until child is one year old]

      Compare prevalence of depression symptoms between intervention and control group 6-8 weeks after births and 6 plus 12 months after birth.

    Other Outcome Measures

    1. Parents' self-efficacy breastfeeding their child [From birth until child is one year old]

      Compare how parents' self-efficacy breastfeeding their child is improved

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Being pregnant or partner of a person who is pregnant in pregnancy week 20-32

    • All parents with language skills enabling them to fill out questionnaires, participate in interviews and read information.

    • Being resident in Stockholm Region

    Exclusion Criteria:
    • Parents without adequate Swedish language skills

    • Parents resident outside the Stockholm Region

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Region Stockholm/Karolinska Institutet Stockholm Sweden

    Sponsors and Collaborators

    • Region Stockholm

    Investigators

    • Principal Investigator: Marina Taloyan, Assoc.Prof., Region Stockholm

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marina Taloyan, Associate professor, Region Stockholm
    ClinicalTrials.gov Identifier:
    NCT06044636
    Other Study ID Numbers:
    • BREASTFEEDING
    First Posted:
    Sep 21, 2023
    Last Update Posted:
    Sep 21, 2023
    Last Verified:
    Sep 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Marina Taloyan, Associate professor, Region Stockholm
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 21, 2023